213 related articles for article (PubMed ID: 36947815)
1. Structural variation cooperates with permissive chromatin to control enhancer hijacking-mediated oncogenic transcription.
Botten GA; Zhang Y; Dudnyk K; Kim YJ; Liu X; Sanders JT; Imanci A; Droin N; Cao H; Kaphle P; Dickerson KE; Kumar KR; Chen M; Chen W; Solary E; Ly P; Zhou J; Xu J
Blood; 2023 Jul; 142(4):336-351. PubMed ID: 36947815
[TBL] [Abstract][Full Text] [Related]
2. Activation of TLX3 and NKX2-5 in t(5;14)(q35;q32) T-cell acute lymphoblastic leukemia by remote 3'-BCL11B enhancers and coregulation by PU.1 and HMGA1.
Nagel S; Scherr M; Kel A; Hornischer K; Crawford GE; Kaufmann M; Meyer C; Drexler HG; MacLeod RA
Cancer Res; 2007 Feb; 67(4):1461-71. PubMed ID: 17308084
[TBL] [Abstract][Full Text] [Related]
3. Enhancer Hijacking Drives Oncogenic
Montefiori LE; Bendig S; Gu Z; Chen X; Pölönen P; Ma X; Murison A; Zeng A; Garcia-Prat L; Dickerson K; Iacobucci I; Abdelhamed S; Hiltenbrand R; Mead PE; Mehr CM; Xu B; Cheng Z; Chang TC; Westover T; Ma J; Stengel A; Kimura S; Qu C; Valentine MB; Rashkovan M; Luger S; Litzow MR; Rowe JM; den Boer ML; Wang V; Yin J; Kornblau SM; Hunger SP; Loh ML; Pui CH; Yang W; Crews KR; Roberts KG; Yang JJ; Relling MV; Evans WE; Stock W; Paietta EM; Ferrando AA; Zhang J; Kern W; Haferlach T; Wu G; Dick JE; Klco JM; Haferlach C; Mullighan CG
Cancer Discov; 2021 Nov; 11(11):2846-2867. PubMed ID: 34103329
[TBL] [Abstract][Full Text] [Related]
4. Elevated enhancer-oncogene contacts and higher oncogene expression levels by recurrent CTCF inactivating mutations in acute T cell leukemia.
Smits WK; Vermeulen C; Hagelaar R; Kimura S; Vroegindeweij EM; Buijs-Gladdines JGCAM; van de Geer E; Verstegen MJAM; Splinter E; van Reijmersdal SV; Buijs A; Galjart N; van Eyndhoven W; van Min M; Kuiper R; Kemmeren P; Mullighan CG; de Laat W; Meijerink JPP
Cell Rep; 2023 Apr; 42(4):112373. PubMed ID: 37060567
[TBL] [Abstract][Full Text] [Related]
5. Genome-wide detection of enhancer-hijacking events from chromatin interaction data in rearranged genomes.
Wang X; Xu J; Zhang B; Hou Y; Song F; Lyu H; Yue F
Nat Methods; 2021 Jun; 18(6):661-668. PubMed ID: 34092790
[TBL] [Abstract][Full Text] [Related]
6. Non-coding Transcription Instructs Chromatin Folding and Compartmentalization to Dictate Enhancer-Promoter Communication and T Cell Fate.
Isoda T; Moore AJ; He Z; Chandra V; Aida M; Denholtz M; Piet van Hamburg J; Fisch KM; Chang AN; Fahl SP; Wiest DL; Murre C
Cell; 2017 Sep; 171(1):103-119.e18. PubMed ID: 28938112
[TBL] [Abstract][Full Text] [Related]
7. Subtype-specific 3D genome alteration in acute myeloid leukaemia.
Xu J; Song F; Lyu H; Kobayashi M; Zhang B; Zhao Z; Hou Y; Wang X; Luan Y; Jia B; Stasiak L; Wong JH; Wang Q; Jin Q; Jin Q; Fu Y; Yang H; Hardison RC; Dovat S; Platanias LC; Diao Y; Yang Y; Yamada T; Viny AD; Levine RL; Claxton D; Broach JR; Zheng H; Yue F
Nature; 2022 Nov; 611(7935):387-398. PubMed ID: 36289338
[TBL] [Abstract][Full Text] [Related]
8. Integrated paired-end enhancer profiling and whole-genome sequencing reveals recurrent
Ooi WF; Nargund AM; Lim KJ; Zhang S; Xing M; Mandoli A; Lim JQ; Ho SWT; Guo Y; Yao X; Lin SJ; Nandi T; Xu C; Ong X; Lee M; Tan AL; Lam YN; Teo JX; Kaneda A; White KP; Lim WK; Rozen SG; Teh BT; Li S; Skanderup AJ; Tan P
Gut; 2020 Jun; 69(6):1039-1052. PubMed ID: 31542774
[TBL] [Abstract][Full Text] [Related]
9. Aberrant TAL1 activation is mediated by an interchromosomal interaction in human T-cell acute lymphoblastic leukemia.
Patel B; Kang Y; Cui K; Litt M; Riberio MS; Deng C; Salz T; Casada S; Fu X; Qiu Y; Zhao K; Huang S
Leukemia; 2014 Feb; 28(2):349-61. PubMed ID: 23698277
[TBL] [Abstract][Full Text] [Related]
10. A far downstream enhancer for murine Bcl11b controls its T-cell specific expression.
Li L; Zhang JA; Dose M; Kueh HY; Mosadeghi R; Gounari F; Rothenberg EV
Blood; 2013 Aug; 122(6):902-11. PubMed ID: 23741008
[TBL] [Abstract][Full Text] [Related]
11. T/myeloid mixed phenotype acute leukaemia harbouring TLX3::BCL11B with TLX3 activation.
Botten GA; Zhang Y; Fuda F; Koduru P; Weinberg OK; Slone TL; Zheng R; Dickerson KE; Gagan JR; Chen W
Br J Haematol; 2024 Feb; ():. PubMed ID: 38385580
[TBL] [Abstract][Full Text] [Related]
12. 3D genome alterations associated with dysregulated HOXA13 expression in high-risk T-lineage acute lymphoblastic leukemia.
Yang L; Chen F; Zhu H; Chen Y; Dong B; Shi M; Wang W; Jiang Q; Zhang L; Huang X; Zhang MQ; Wu H
Nat Commun; 2021 Jun; 12(1):3708. PubMed ID: 34140506
[TBL] [Abstract][Full Text] [Related]
13. HOX11L2/TLX3 is transcriptionally activated through T-cell regulatory elements downstream of BCL11B as a result of the t(5;14)(q35;q32).
Su XY; Della-Valle V; Andre-Schmutz I; Lemercier C; Radford-Weiss I; Ballerini P; Lessard M; Lafage-Pochitaloff M; Mugneret F; Berger R; Romana SP; Bernard OA; Penard-Lacronique V
Blood; 2006 Dec; 108(13):4198-201. PubMed ID: 16926283
[TBL] [Abstract][Full Text] [Related]
14. Epigenome-wide analysis of T-cell large granular lymphocytic leukemia identifies BCL11B as a potential biomarker.
Johansson P; Laguna T; Ossowski J; Pancaldi V; Brauser M; Dührsen U; Keuneke L; Queiros A; Richter J; Martín-Subero JI; Siebert R; Schlegelberger B; Küppers R; Dürig J; Murga Penas EM; Carillo-de Santa Pau E; Bergmann AK
Clin Epigenetics; 2022 Nov; 14(1):148. PubMed ID: 36376973
[TBL] [Abstract][Full Text] [Related]
15. TP63, SOX2, and KLF5 Establish a Core Regulatory Circuitry That Controls Epigenetic and Transcription Patterns in Esophageal Squamous Cell Carcinoma Cell Lines.
Jiang YY; Jiang Y; Li CQ; Zhang Y; Dakle P; Kaur H; Deng JW; Lin RY; Han L; Xie JJ; Yan Y; Doan N; Zheng Y; Mayakonda A; Hazawa M; Xu L; Li Y; Aswad L; Jeitany M; Kanojia D; Guan XY; Said JW; Yang W; Fullwood MJ; Lin DC; Koeffler HP
Gastroenterology; 2020 Oct; 159(4):1311-1327.e19. PubMed ID: 32619460
[TBL] [Abstract][Full Text] [Related]
16. 14q32 rearrangements deregulating BCL11B mark a distinct subgroup of T-lymphoid and myeloid immature acute leukemia.
Di Giacomo D; La Starza R; Gorello P; Pellanera F; Kalender Atak Z; De Keersmaecker K; Pierini V; Harrison CJ; Arniani S; Moretti M; Testoni N; De Santis G; Roti G; Matteucci C; Bassan R; Vandenberghe P; Aerts S; Cools J; Bornhauser B; Bourquin JP; Piazza R; Mecucci C
Blood; 2021 Sep; 138(9):773-784. PubMed ID: 33876209
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional dysregulation by aberrant enhancer activation and rewiring in cancer.
Okabe A; Kaneda A
Cancer Sci; 2021 Jun; 112(6):2081-2088. PubMed ID: 33728716
[TBL] [Abstract][Full Text] [Related]
18. Structural variants drive context-dependent oncogene activation in cancer.
Xu Z; Lee DS; Chandran S; Le VT; Bump R; Yasis J; Dallarda S; Marcotte S; Clock B; Haghani N; Cho CY; Akdemir KC; Tyndale S; Futreal PA; McVicker G; Wahl GM; Dixon JR
Nature; 2022 Dec; 612(7940):564-572. PubMed ID: 36477537
[TBL] [Abstract][Full Text] [Related]
19. Control of p53-dependent transcription and enhancer activity by the p53 family member p63.
Karsli Uzunbas G; Ahmed F; Sammons MA
J Biol Chem; 2019 Jul; 294(27):10720-10736. PubMed ID: 31113863
[TBL] [Abstract][Full Text] [Related]
20. 5C analysis of the Epidermal Differentiation Complex locus reveals distinct chromatin interaction networks between gene-rich and gene-poor TADs in skin epithelial cells.
Poterlowicz K; Yarker JL; Malashchuk I; Lajoie BR; Mardaryev AN; Gdula MR; Sharov AA; Kohwi-Shigematsu T; Botchkarev VA; Fessing MY
PLoS Genet; 2017 Sep; 13(9):e1006966. PubMed ID: 28863138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
